Figure 3.
Serum PD-time profiles for crizanlizumab. Mean and median serum PD-time profiles for the crizanlizumab 5.0 and 7.5 mg/kg dose groups at starting dose (A) and steady state (PDS2) (B).
Serum PD-time profiles for crizanlizumab. Mean and median serum PD-time profiles for the crizanlizumab 5.0 and 7.5 mg/kg dose groups at starting dose (A) and steady state (PDS2) (B).
